(Q48324978)

English

Treatment of infantile Pompe disease with alglucosidase alpha: the UK experience.

scientific article published on 24 September 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20865334

Treatment of infantile Pompe disease with alglucosidase alpha: the UK experience. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20865334

author name string

Anupam Chakrapani

1

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20865334

Ashok Vellodi

2

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20865334

Peter Robinson

3

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20865334

Simon Jones

4

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20865334

J E Wraith

5

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20865334

publication date

24 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20865334

Journal of Inherited Metabolic Disease

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20865334

33

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20865334

6

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20865334

747-750

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20865334

https://scigraph.springernature.com/pub.10.1007/s10545-010-9206-3

0 references

A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20865334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20865334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants

1 reference

https://pubmed.ncbi.nlm.nih.gov/20865334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20865334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20865334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/20865334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10545-010-9206-3

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20865334

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20865334

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48324978&oldid=1407107950"